Blog

General

Responses to COVID-19: latest options for treatment

Art AIDS America: a selection

Open letter: on futility of proposed UK PrEP study

Legal threat causes NHS England to rethink PrEP access to prevent HIV

WHO 2015 guidelines: newly recommended generic ART products on the way for adults

CHAI’s ARV market report predicts that new drugs and formulations will drive the next major drop in treatment costs

Buying generic medication online in the the UK: PrEP and hepatitis C

NHS PrEP access: ACT-UP demo and community statements

PrEP talk from Glasgow online as a webcast

PrEP: a community perspective (November 2014)

HIV and young gay people in London: two short online videos

Generic ARVs in the UK – background paper for drug commissioning

d4T – Time to move on

Treatment optimisation: technical updates from WHO

Pictures from the march in Washington

IAS 2012 webcasts – now online with live streaming